HPV Vaccine & Decline in Cervical Lesions

on May 30, 2017 in news

5/30/17

 

Healio reports more clinical evidence for continuing to improve HPV immunization rates.  The study was done in Connecticut with women age 21 to 39 years from 2008 to 2015. Linda M. Niccolai, PhD from the Connecticut emerging infections program at Yale School of Public Health and colleagues wrote “ Though evidence of the impact of HPV vaccines on cervical infections and genital warts is growing, less is known about trends in precancerous high grade cervical lesions.”